Birth of children in space: A biological disaster?

Is it possible to conceive and give birth in space? Current scientific assessments remain cautious and, in many cases, pessimistic, highlighting risks that may be both unexpected and concerning.

Ambitious plans for the colonization of the Moon and Mars typically focus on launch systems, habitats, life-support infrastructure, and conceptual designs. However, behind this technological outlook lies a more fundamental and unresolved question: whether humans can safely reproduce beyond Earth.

While policymakers and corporations emphasize payload capacity and mission architecture, researchers increasingly point out a critical gap in knowledge. Long-term human presence in space may be achieved before there is a clear understanding of how pregnancy, embryonic development, and childbirth are affected by extraterrestrial environments.

Let’s talk about this in more detail.

TABLE OF CONTENTS:

Pregnancy in Space: Humanity Is Not Ready

An international team of specialists in reproductive medicine, bioethics, and space medicine recently published a report in Reproductive BioMedicine Online. The conclusion is direct: humanity is not prepared for pregnancy in space, and postponing this issue could lead to a situation where the necessary technologies exist, but clear regulations, ethical frameworks, and safe practices do not.

Clinical embryologist and director of the International IVF Initiative, Giles Palmer, emphasizes that treating space reproduction as distant science fiction is a misleading assumption with potential risks.

“We do not support attempts at reproduction in space under current conditions,” he notes. “However, with the return of lunar missions and concrete plans for missions to Mars, the associated risks will only increase. If these issues are not addressed now, the opportunity for effective regulation may be lost.”

In other words, the question is not whether humans will attempt to have children in space, but whether it may occur before adequate preparation for the medical, ethical, and legal consequences is in place. In that case, the concept of a “spacefaring future” risks becoming not a breakthrough, but a costly and potentially hazardous human experiment.

Two Revolutions Converging

Giles Palmer points to a symbolic yet concerning convergence. Half a century ago, humanity achieved two breakthroughs that were considered largely independent at the time: landing on the Moon and demonstrating the viability of in vitro fertilization.

Today, these two developments are beginning to intersect, raising significantly more questions than answers.

Space is gradually shifting from a domain of short-term expeditions and symbolic achievements to an operational environment where humans may spend months, and eventually years. At the same time, assisted reproductive technologies (ART) have reached a level of automation and standardization that would have seemed unrealistic a decade ago. Some processes can already be performed remotely, algorithmically managed, and scaled. This convergence makes the question of reproduction beyond Earth a practical concern rather than a purely theoretical one.

In this context, the issue is no longer whether it should be considered, but rather that, without defined rules and boundaries, actions may proceed without adequate oversight. For this reason, the authors of the report advocate for the development of a global regulatory framework governing fertility research and reproduction in space.

Such a framework would involve an international ethical body responsible for establishing guidelines before commercial companies and government agencies begin pursuing independent approaches. Without shared standards, space risks becoming not a domain of controlled scientific inquiry, but an environment of unregulated experimentation with potentially significant consequences.

Space as a Hostile Environment for Human Biology

Humans are a product of evolution adapted to survive within a very specific environment: the surface of Earth. Constant gravity, a dense atmosphere, and the presence of a magnetic field have shaped human physiology, defense mechanisms, and recovery processes over millions of years. These conditions are fundamental to normal biological function.

In space, none of these natural buffers are present. There is no magnetic shielding, no stable gravity, and no familiar biological rhythm. For the reproductive system, this represents a combination of stressors – primarily cosmic radiation and microgravity – factors with which human biology has no evolutionary experience.

Ionizing radiation can directly damage DNA, disrupt gamete formation, and increase the risk of cancer. This is particularly critical during embryonic development, where even minor mutations at early stages may lead to disproportionately severe outcomes. Microgravity, in turn, interferes with hormonal regulation, alters the quality of reproductive cells, and may affect normal embryonic development, although the underlying mechanisms remain only partially understood.

Additional risks arise from the operational conditions of space environments. Toxic regolith dust capable of penetrating habitats, chemical contamination within closed systems, limited resources, continuous recycling of air and water, and microbial loads in life-support systems all contribute to a baseline of chronic physiological stress that has no direct equivalent on Earth.

Psychological factors are also significant. Prolonged stress, isolation, sensory deprivation, and disruption of circadian rhythms directly affect hormonal balance and, consequently, fertility. During missions lasting months or potentially years, these factors accumulate rather than act in isolation. In worst-case scenarios, this may lead not only to functional impairments of the reproductive system but also to epigenetic changes that could, in theory, be transmitted to subsequent generations.

This is where technological optimism encounters biological constraints: the ability of humans to survive in space does not necessarily imply the capacity for safe and sustainable reproduction without long-term consequences.

What Do Animal Experiments Show?

Initial attempts to determine whether mammals can reproduce in space date back to the late 1970s. One of the most cited experiments took place in 1979 aboard the Soviet satellite Bion 5, which carried five female and two male rats. After 19 days in orbit, the animals were allowed to mate. The outcome was notable and concerning: there was no successful reproduction.

Some of the female rats did become pregnant, but embryonic development was halted due to resorption. Others experienced severe disruptions to their reproductive cycles, including the absence of ovulation. The experiment demonstrated that the mere possibility of mating does not guarantee reproductive success when the body is exposed to microgravity and elevated radiation levels.

Significant progress came much later with advances in modern biotechnology. In 2021, a Japanese research team sent frozen two-cell mouse embryos to the International Space Station. After thawing, the embryos were cultured for four days in microgravity and successfully developed to the blastocyst stage. Genetic analysis revealed no major abnormalities, providing key evidence that early stages of development can, in principle, remain viable beyond Earth.

Even more revealing were experiments using freeze-dried mouse sperm stored on the International Space Station for six years. Upon return to Earth, the sperm was used for fertilization, resulting in hundreds of healthy mice that later produced their own offspring. This demonstrates that, with proper protection of genetic material, certain components of the reproductive system can withstand prolonged exposure to space conditions.

However, these successes have clear limitations. All positive outcomes were achieved without actual pregnancy occurring in space, as key developmental stages took place either before launch or after return to Earth. To date, science can only confirm that individual stages of reproduction can be conducted in space. The full reproductive cycle – from conception to birth – remains largely unexplored and potentially hazardous.

For this reason, animal experiments signal caution rather than clearance: progress is possible, but only slowly and with constant awareness of the potential consequences of mistakes.

Women in Space: The Largest Data Gap

The most concerning aspect of the discussion is how little is known about the effects of space on female fertility. As of 2024, only 155 women have traveled to space. This number is far too small to provide any statistically reliable medical sample. For comparison, it is insufficient even for cautious conclusions, let alone long-term predictions.

Existing data primarily come from short shuttle-era missions. These records suggest that post-flight pregnancies generally proceeded without complications. However, this represents only a limited and possibly less problematic portion of the overall picture. When it comes to extended stays aboard the International Space Station, or future missions to the Moon or Mars, the dataset becomes extremely sparse. In practice, researchers are working with isolated observations rather than systematic knowledge.

In this context, animal experiments should be seen not as abstract warnings, but as direct alerts. Exposure to ionizing radiation and microgravity can disrupt menstrual cycles, alter estrogen and progesterone receptor expression, and negatively affect ovarian and uterine function. In other words, the concern is not minor irregularities but systemic interference with hormonal and reproductive regulation.

The problem is that human data capable of confirming or refuting these risks simply do not exist. As space programs move toward extended human presence beyond Earth, this knowledge gap becomes more than an academic issue – it represents a potential threat. Ignoring it would amount to undertaking an experiment with extremely high stakes, where the cost of error could affect the health of future generations.

IVF in Space

Although it sounds like science fiction, assisted reproductive technologies have long moved beyond the realm of imagination. According to Giles Palmer, modern systems for gamete storage, embryo culture, and genetic analysis are sufficiently miniaturized and automated that adapting them to orbital conditions is primarily an engineering challenge rather than a question of feasibility.

In practice, this means that ready-made technological workflows can be housed in compact modules with minimal human intervention. This makes IVF particularly appealing for space programs: rather than attempting a full-term pregnancy in microgravity, only the most controllable early stages of reproduction would need to be conducted in space.

The private sector is already moving in this direction. SpaceBorn United is developing a prototype orbital embryo incubator designed to support fertilization and early development under artificial gravity. The concept is pragmatic: the incubator remains in orbit for only a few days before returning to Earth, where the biological material undergoes detailed analysis.

Initial tests are being conducted with mouse cells, representing the safest and most ethically acceptable stage. Subsequent phases are planned to involve human stem cells, and eventually, human gametes. While this does not constitute actual “birth in space,” it represents a direct technological step toward that possibility.

Herein lies a central challenge. The development of such systems is outpacing the establishment of international ethical standards and regulations. In this scenario, space risks becoming not a controlled laboratory but a testing ground where commercial interests advance faster than public discourse. Without predefined boundaries, decisions about how far to go and when will be made retroactively – driven by technological capability rather than responsibility.

Astronauts and IVF: A Real Case with Real Challenges

The question of reproduction in space is no longer purely theoretical; it already affects real people and concrete decisions. A notable example is Kelly Jerrard, the 90th woman to fly in space. In 2024, she underwent in vitro fertilization to address secondary infertility.

Her experience highlights the complexity of reproductive choices when a profession involves exposure to elevated radiation, parabolic flights, intense physical demands, and chronic stress. Even without extended long-duration missions, these factors combine to create cumulative effects whose outcomes are difficult to predict.

It is also important to note that Jerrard is not an exception. For many astronauts, fertility concerns arise long before their first flight – well before any clinical symptoms appear. For this reason, reproductive specialists increasingly recommend that those planning a space career consider freezing eggs, sperm, or embryos in advance.

Currently, this is essentially the only method that can meaningfully improve the chances of a healthy pregnancy after returning from a mission. At the same time, it implicitly acknowledges that even modern medicine is not fully equipped to counteract the effects of the space environment on reproductive health.

This case underscores a key point: discussions of IVF and fertility in the context of space are no longer theoretical debates about the distant future. They involve real decisions that people must make today, without complete information about long-term consequences. It is precisely here that the line between personal choice and systemic responsibility becomes dangerously blurred.

The Window for Intervention Is Closing

As humanity’s space ambitions grow, the need for clear and strict rules regarding human reproduction beyond Earth becomes increasingly urgent. The authors of the report are unequivocal: there will be no experiments involving pregnant humans in space. Not now. Not “as part of pilot programs.” Not in decades to come. Simply put – no.

All research must be limited to animal models, simulated environments, and technologies that reproduce space conditions without directly endangering humans. This is not precaution for its own sake; it is the only ethically acceptable approach if we wish to avoid repeating the mistakes of early biomedicine, now on an interplanetary scale.

Giles Palmer emphasizes that entering this new domain requires immediate action rather than a gradual “wait and see” approach. “We need an international regulatory framework and a shared ethics committee before practice outpaces regulation,” he stresses. Such a body would not only oversee the safety and transparency of research but also protect those who have not yet been born – future generations who may live and work beyond Earth.

It is also important to note that these decisions will not remain purely “space-focused.” Research on the effects of microgravity on hormonal balance, DNA protection from radiation, or gamete stability under extreme conditions may have entirely terrestrial applications – from cancer treatment to supporting people with fertility challenges.

Giles Palmer emphasizes that IVF in space is neither a futuristic whim nor the plot of a science-fiction novel. It is a logical extension of technologies that are already miniaturized, automated, and increasingly supported by artificial intelligence algorithms. In other words, technical capabilities are advancing faster than society can fully understand their implications.

This is why the window for intervention is rapidly closing. Technologies are moving forward at “space speed,” and if regulation cannot keep pace, ethics risks becoming little more than a belated academic review of developments that have long since escaped control.

Read also:

Childbirth in Space: Science Fiction or Biological Catastrophe?